X-ray lightsource at DESY identifies promising candidates for COVID drugs
Electron density map of the most antiviral active ingredient calpeptin (yellow) binding at the main protease. © DESY/Sebastian Günther
At DESY's high-brilliance X-ray light source PETRA III, a team from more than 30 research institutions has identified several candidates for active substances against the coronavirus SARS-CoV-2. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. The MX team from HZB examined part of the measurement data with special analysis algorithms in order to identify suitable active substances. The study has now been published in the renowned journal Science.
In a so-called X-ray screening, the researchers, under the leadership of DESY, tested almost 6000 known active substances that already exist for the treatment of other diseases in a short amount of time. After measuring about 7000 samples, the team was able to identify a total of 37 substances that bind to the main protease (Mpro) of the SARS-CoV-2 virus, as the scientists report online today in the journal Science. Seven of these substances inhibit the activity of the protein and thus slow down the multiplication of the virus. Two of them do this so promisingly that they are currently under further investigation in preclinical studies. This drug screening – probably the largest of its kind – also revealed a new binding site on the main protease of the virus to which drugs can couple.
“The active substances Calpeptin and Pelitinib clearly showed the highest antivirality with good cell compatibility. Our cooperation partners have therefore already started preclinical investigations with these two substances,” explains DESY researcher Sebastian Günther, first author of the Science publication.
In addition to DESY scientists, researchers from the Universities of Hamburg and Lübeck, the Bernhard Nocht Institute for Tropical Medicine, the Fraunhofer Institute for Translational Medicine and Pharmacology, the Heinrich Pette Institute, the European XFEL, the European Molecular Biology Laboratory EMBL, the Max Planck Society, the Helmholtz-Zentrum Berlin and other institutions are involved in the work.
Note: This is a shortened version of the full text of the press release published at DESY Website.
- Disorder creates new properties in compound semiconductorsAn international research team has demonstrated that the intrinsic disorder of the compound semiconductor CuInSnS₄ can be exploited to influence its optical properties. While the atomic vibrations also sense the local disorder, their response is averaged over many different local environments and therefore appear isotropic, as expected for a cubic crystal. In contrast, the optical excitations, known as excitons, are much more sensitive to the local arrangement of atoms. Surprisingly, they show a direction-dependent optical response even though the average crystal structure is cubic. These findings shed new light on the relationship between disorder and material properties, opening up new options for targeted 'disorder engineering' in optoelectronic and photocatalytic devices.
- Perovskite solar cells: Predictions of long-term stabilityReliable statements about the long-term stability of perovskite solar cells are still difficult to make. However, a new study by Dr Carolin Ulbrich’s team, published in the renowned journal Joule, highlights which methods are useful for this purpose and identifies areas where further research is needed.
- Superconducting TES array X-ray spectrometer goes into operation at BESSY IIEurope's first and only TES-spectrometer at a synchrotron source is now in operation at BESSY II, developed within a collaboration between the HZB, the MPI-CEC (Mühlheim-an-der-Ruhr, Germany) and the NIST (Boulder CO, USA). The photon detection efficiency of the new instrument exceeds that of wavelength-dispersive X-ray emission spectrometers by a factor of 100 to 1000. It will be used to investigate the electronic properties of atomically thin layers, nanostructures and highly diluted atomic and molecular samples. The team is looking forward to receiving exciting research proposals from the user community.